Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A novel class of blood glucose-lowering treatment for type 2 diabetes has launched in the UK after gaining European approval, offering GPs new treatment options.
Dapagliflozin (Forxiga) belongs to a new drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by reducing the amount of glucose reabsorbed by the kidney.
http://www.gponline.com/News/article/1161434/first-in-class-diabetes-drug-launches-uk/
Dapagliflozin (Forxiga) belongs to a new drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by reducing the amount of glucose reabsorbed by the kidney.
http://www.gponline.com/News/article/1161434/first-in-class-diabetes-drug-launches-uk/